Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Klebsiella pneumoniae subsp. pneumoniae DNA mismatch repair protein mutL (mutL), partial CSB-YP409232KAX
CSB-EP409232KAX
CSB-BP409232KAX
CSB-MP409232KAX
CSB-EP409232KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae subsp. pneumoniae 30S ribosomal protein S6 (rpsF) CSB-YP409233KAX
CSB-EP409233KAX
CSB-BP409233KAX
CSB-MP409233KAX
CSB-EP409233KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae subsp. pneumoniae Inosose dehydratase (iolE) CSB-YP409234KAX
CSB-EP409234KAX
CSB-BP409234KAX
CSB-MP409234KAX
CSB-EP409234KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae subsp. pneumoniae Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP409235KAX
CSB-EP409235KAX
CSB-BP409235KAX
CSB-MP409235KAX
CSB-EP409235KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae subsp. pneumoniae Trp operon repressor (trpR) CSB-YP409236KAX
CSB-EP409236KAX
CSB-BP409236KAX
CSB-MP409236KAX
CSB-EP409236KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae subsp. pneumoniae Probable phosphoglycerate mutase GpmB (gpmB) CSB-YP409237KAX
CSB-EP409237KAX
CSB-BP409237KAX
CSB-MP409237KAX
CSB-EP409237KAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Glutamyl-tRNA reductase (hemA) CSB-YP409238AUP
CSB-EP409238AUP
CSB-BP409238AUP
CSB-MP409238AUP
CSB-EP409238AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Uracil phosphoribosyltransferase (upp) CSB-YP409239AUP
CSB-EP409239AUP
CSB-BP409239AUP
CSB-MP409239AUP
CSB-EP409239AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens ATP phosphoribosyltransferase (hisG) CSB-YP409240AUP
CSB-EP409240AUP
CSB-BP409240AUP
CSB-MP409240AUP
CSB-EP409240AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP409241AUP
CSB-EP409241AUP
CSB-BP409241AUP
CSB-MP409241AUP
CSB-EP409241AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 10 kDa chaperonin (groS) CSB-YP409242AUP
CSB-EP409242AUP
CSB-BP409242AUP
CSB-MP409242AUP
CSB-EP409242AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP409243AUP
CSB-EP409243AUP
CSB-BP409243AUP
CSB-MP409243AUP
CSB-EP409243AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP409244AUP
CSB-EP409244AUP
CSB-BP409244AUP
CSB-MP409244AUP
CSB-EP409244AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Hydroxyethylthiazole kinase (thiM) CSB-YP409245AUP
CSB-EP409245AUP
CSB-BP409245AUP
CSB-MP409245AUP
CSB-EP409245AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens 33 kDa chaperonin (hslO) CSB-YP409246AUP
CSB-EP409246AUP
CSB-BP409246AUP
CSB-MP409246AUP
CSB-EP409246AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Arginine--tRNA ligase (argS), partial CSB-YP409247AUP
CSB-EP409247AUP
CSB-BP409247AUP
CSB-MP409247AUP
CSB-EP409247AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Probable tRNA sulfurtransferase (thiI) CSB-YP409248AUP
CSB-EP409248AUP
CSB-BP409248AUP
CSB-MP409248AUP
CSB-EP409248AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Methylglyoxal synthase (mgsA) CSB-YP409249AUP
CSB-EP409249AUP
CSB-BP409249AUP
CSB-MP409249AUP
CSB-EP409249AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens UPF0297 protein Amet_2459 (Amet_2459) CSB-YP409250AUP
CSB-EP409250AUP
CSB-BP409250AUP
CSB-MP409250AUP
CSB-EP409250AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alkaliphilus metalliredigens Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP409251AUP
CSB-EP409251AUP
CSB-BP409251AUP
CSB-MP409251AUP
CSB-EP409251AUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>